A novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis (PVNS), a rare neoplastic joint disorder, according to new phase I data from Memorial Sloan Kettering Cancer Center and ...
May 14, 2014
0
1
Among patients with advanced non-small cell lung cancer without a mutation of a certain gene (EGFR), conventional chemotherapy, compared with treatment using epidermal growth factor receptor tyrosine kinase inhibitors, was ...
Apr 8, 2014
0
0
Tumor cells are picky about where they live. In the wrong environment, they fail to reach their potential. But put those same cells on the right bit of real estate, and they grow like mad. Researchers at Fox Chase Cancer ...
Apr 6, 2014
1
0
(Medical Xpress)—If life were simple, a disease could be treated with one drug that hits one molecular target, like striking a piano key. Instead, researchers wrestle with the fact that most drugs hit multiple targets in ...
Mar 20, 2014
0
0
Patients with terminal forms of leukaemia and lymphoma who have run out of treatment options could soon benefit from a new drug, which not only puts an end to chemotherapy and has virtually no side effects but also improves ...
Mar 19, 2014
0
0
(HealthDay)—An experimental drug may extend the lives of people with certain hard-to-treat forms of leukemia and lymphoma—without the need for traditional chemotherapy, according to two studies released Wednesday.
Mar 12, 2014
0
0
A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports* ...
Mar 10, 2014
0
0
Three very different people gathered recently at University of Colorado Hospital. They were linked by leukemia.
Feb 28, 2014
1
29
Patients from less affluent backgrounds have a greater chance of dying from a form of chronic blood cancer than those from more affluent areas, according to a comprehensive study carried out by researchers at the University ...
Feb 4, 2014
0
0
Much of the debate in Alzheimer's disease (AD) has focused on whether the protein amyloid-beta or the tau protein is the symptom or the cause of the disease.
Dec 15, 2013
0
0
